Janux Therapeutics, Inc.
JANXNASDAQHealthcare● Active
$13.48
+$0.12(+0.90%)
Market Cap$822117879
P/E Ratio—
52W High$35.34
52W Low$12.12
Janux Therapeutics, Inc.（JANX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · JANX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.00M | $10.59M | $8.08M | $8.61M | $3.64M |
| Cost of Revenue | $2.03M | $2.06M | $1.96M | $0.84M | $0.00M |
| Gross Profit | $7.97M | $8.53M | $6.13M | $7.77M | $3.64M |
| Gross Margin %(computed) | 79.71% | 80.54% | 75.81% | 90.23% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $125.90M | $68.39M | $54.92M | $53.44M | $26.24M |
| G&A Expenses | $41.77M | $41.05M | $26.14M | $22.26M | $10.33M |
| Total Operating Expenses | $165.64M | $107.38M | $79.11M | $74.86M | $36.57M |
| Operating Income | ($157.67M) | ($98.85M) | ($72.98M) | ($67.09M) | ($32.93M) |
| Operating Margin %(computed) | — | -933.58% | -902.87% | -779.04% | -905.39% |
| Interest Income | $44.04M | $29.85M | $14.69M | $4.03M | $0.26M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($113.63M) | ($68.99M) | ($58.29M) | ($63.06M) | ($32.67M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($113.63M) | ($68.99M) | ($58.29M) | ($63.06M) | ($32.67M) |
| Net Margin %(computed) | — | -651.62% | -721.18% | -732.22% | -898.32% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-0.79 |
| Wtd Avg Shares | 61.97M | 53.75M | 44.02M | 41.47M | 41.24M |
| EBITDA | ($111.60M) | ($96.79M) | ($71.02M) | ($66.25M) | ($32.82M) |
| EBITDA Margin %(computed) | — | -914.12% | -878.68% | -769.28% | -902.28% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Janux Therapeutics, Inc.
关于Janux Therapeutics, Inc.（JANX）损益表
Janux Therapeutics, Inc.（JANX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，JANX实现营收$0.01B，毛利润$0.01B（毛利率79.71%），净利润($0.11B)（净利率-1136.25%）。
常见问题
JANX · 4 问Janux Therapeutics, Inc.（JANX）2025财年营收为$0.01B，同比down5.6%。
JANX revenueJANX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08